483
Kedrion Biopharma Inc.Kedrion Biopharma Inc. – FDA 483, Jun 25, 2021
Record Details
An FDA inspection of Medisca Biopharma Inc. in Melville, NY, an API and Intermediate Manufacturer, revealed significant deficiencies in facility cleanliness and process control. Inspectors observed powdery substances and dried matter on equipment labeled as "clean," indicating inadequate cleaning practices. Furthermore, there was no current assessment of the cleaning process, including microbial control, which could impact product quality.
View Company Profile
ID · 35995803-c3d0-4321-b6b6-3f34abdff6af
Other documents for Kedrion Biopharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.